CPRX Q2 2019 Earnings — Catalyst Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

CPRXCatalyst Pharmaceuticals, Inc.

$3B

Q2 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$29M

Gross Profit

$25M85.2% margin

Operating Income

$11M38.0% margin

Net Income

$11M38.0% margin

EPS (Diluted)

$0.10

QoQ Revenue Growth

+131.7%

Cash Flow

Operating Cash Flow

$14M

Free Cash Flow

$14M

Stock-Based Comp.

$924,996

Balance Sheet

Total Assets

$78M

Total Liabilities

$15M

Stockholders' Equity

$63M

Cash & Equivalents

$23M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$29M	$0	—
Gross Profit	$25M	-$4M	+763.4%
Operating Income	$11M	-$6M	+273.0%
Net Income	$11M	-$6M	+283.7%